Status:
COMPLETED
Emollient 'Plus' vs Urea 10% for Mild-Moderate Atopic Dermatitis
Lead Sponsor:
Dr. Soetomo General Hospital
Collaborating Sponsors:
L'Oreal
Conditions:
Dermatitis, Atopic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness and tolerability of an Emollient Aqua Posae + Microesyl compared to urea 10% in patients with mild-moderate atopic dermatitis The main ...
Eligibility Criteria
Inclusion
- Male or female aged ≥18 years
- AD patients who meet the criteria for AD diagnosis according to the Hanifin-Rajka criteria.
- Patients with mild-moderate AD according to the SCORAD index.
- Patients who have AD lesions on the hands and/or feet.
- Patients with good general condition.
- Patients are willing to participate in the study and sign the informed consent.
Exclusion
- Pregnant and lactating patients.
- Patients with a history of allergies to ingredients contained in moisturizers
- Patients who clinically have other skin diseases such as psoriasis, seborrheic dermatitis, contact dermatitis or AD with secondary infections that can affect the SCORAD index parameters, skin hydration, skin pH and side effects on the skin area being assessed.
- Patients receiving topical or systemic immunomodulatory and/or immunosuppressant therapy.
- Patients receiving topical and/or systemic antibiotic therapy
- Patients receiving systemic antihistamine therapy (patients who require antihistamines during the study will be recorded on the observation sheet)
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06553417
Start Date
June 1 2023
End Date
December 29 2023
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Soetomo General Hospital
Surabaya, East Java, Indonesia, 60286